These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8904619)

  • 21. Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutation.
    Brockmöller J; Rost KL; Gross D; Schenkel A; Roots I
    Pharmacogenetics; 1995 Apr; 5(2):80-8. PubMed ID: 7663532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-dose kinetics of clomipramine: relationship to the sparteine and S-mephenytoin oxidation polymorphisms.
    Nielsen KK; Brøsen K; Hansen MG; Gram LF
    Clin Pharmacol Ther; 1994 May; 55(5):518-27. PubMed ID: 8181196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in Japanese.
    Ieiri I; Mamiya K; Urae A; Wada Y; Kimura M; Irie S; Amamoto T; Kubota T; Yoshioka S; Nakamura K; Nakano S; Tashiro N; Higuchi S
    Br J Clin Pharmacol; 1997 Apr; 43(4):441-5. PubMed ID: 9146858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation.
    Yasumori T; Li QH; Yamazoe Y; Ueda M; Tsuzuki T; Kato R
    Pharmacogenetics; 1994 Dec; 4(6):323-31. PubMed ID: 7704038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.
    Bertilsson L
    Clin Pharmacokinet; 1995 Sep; 29(3):192-209. PubMed ID: 8521680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals.
    Ishizaki T; Sohn DR; Kobayashi K; Chiba K; Lee KH; Shin SG; Andersson T; Regårdh CG; Lou YC; Zhang Y
    Ther Drug Monit; 1994 Apr; 16(2):214-5. PubMed ID: 8009572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.
    Andersson T; Miners JO; Veronese ME; Birkett DJ
    Br J Clin Pharmacol; 1994 Aug; 38(2):131-7. PubMed ID: 7981013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphism of S-mephenytoin 4'-hydroxylation.
    Daniel HI; Edeki TI
    Psychopharmacol Bull; 1996; 32(2):219-30. PubMed ID: 8783891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.
    Meier UT; Dayer P; Malè PJ; Kronbach T; Meyer UA
    Clin Pharmacol Ther; 1985 Nov; 38(5):488-94. PubMed ID: 4053486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population.
    Basci NE; Bozkurt A; Kortunay S; Isimer A; Sayal A; Kayaalp SO
    Br J Clin Pharmacol; 1996 Dec; 42(6):771-3. PubMed ID: 8971434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese.
    Horai Y; Nakano M; Ishizaki T; Ishikawa K; Zhou HH; Zhou BI; Liao CL; Zhang LM
    Clin Pharmacol Ther; 1989 Aug; 46(2):198-207. PubMed ID: 2758729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population.
    Kubota T; Chiba K; Ishizaki T
    Clin Pharmacol Ther; 1996 Dec; 60(6):661-6. PubMed ID: 8988068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
    Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
    Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective disposition of hexobarbital and its metabolites: relationship to the S-mephenytoin polymorphism in Caucasian and Chinese subjects.
    Adedoyin A; Prakash C; O'Shea D; Blair IA; Wilkinson GR
    Pharmacogenetics; 1994 Feb; 4(1):27-38. PubMed ID: 8004130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study.
    Balian JD; Sukhova N; Harris JW; Hewett J; Pickle L; Goldstein JA; Woosley RL; Flockhart DA
    Clin Pharmacol Ther; 1995 Jun; 57(6):662-9. PubMed ID: 7781266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups.
    Britzi M; Bialer M; Arcavi L; Shachbari A; Kapitulnik T; Soback S
    Ther Drug Monit; 2000 Oct; 22(5):510-6. PubMed ID: 11034254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.
    Xiao ZS; Goldstein JA; Xie HG; Blaisdell J; Wang W; Jiang CH; Yan FX; He N; Huang SL; Xu ZH; Zhou HH
    J Pharmacol Exp Ther; 1997 Apr; 281(1):604-9. PubMed ID: 9103550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.
    Schellens JH; van der Wart JH; Breimer DD
    Br J Clin Pharmacol; 1990 Jun; 29(6):665-71. PubMed ID: 2378787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability.
    Yin OQ; Tomlinson B; Chow AH; Waye MM; Chow MS
    J Clin Pharmacol; 2004 Jun; 44(6):582-9. PubMed ID: 15145965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine.
    Skjelbo E; Brøsen K; Hallas J; Gram LF
    Clin Pharmacol Ther; 1991 Jan; 49(1):18-23. PubMed ID: 1988236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.